Goldacre Clashes With Pharma Over Trial Data Transparency
Executive Summary
The pharmaceutical industry is proud of its 'forward-looking approach' to clinical trial transparency and hopes that it will help answer new research questions. But transparency campaigner Ben Goldacre has stirred controversy by saying that industry is wasting money on sharing patient-level data.